132 related articles for article (PubMed ID: 1323139)
1. Immunoglobulins and complement components levels in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins and complement components in patients with lung cancer.
Oner F; Savaş I; Numanoğlu N
Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
Stiller-Winkler R; Stark M; Idel H
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
[TBL] [Abstract][Full Text] [Related]
4. Immunocomplexes and primary lung cancer.
Lenzini L; Rottoli L; Sestini P; Carriero G; Sani G; Gotti G
Allergol Immunopathol (Madr); 1981; 9(2):119-22. PubMed ID: 6270995
[TBL] [Abstract][Full Text] [Related]
5. [Serum concentration of C3 in primary lung cancer patients].
Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
[No Abstract] [Full Text] [Related]
6. Tumor-associated immunoglobulins in pulmonary carcinoma.
Gerstl B; Eng LF; Bigbee JW
Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
[TBL] [Abstract][Full Text] [Related]
7. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
Paluch E; Ioachim HL
J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoglobulin levels and survival rates in bronchogenic carcinoma patients.
Plesnicar S; Rudolf Z
Neoplasma; 1979; 26(6):721-8. PubMed ID: 542209
[TBL] [Abstract][Full Text] [Related]
9. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
10. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
11. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
Kozielski J; Seweryn J
Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
[No Abstract] [Full Text] [Related]
12. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative levels of serum immunoglobulins, circulating immune complexes and complement proteins in patients with different types of neoplasms.
Gendek-Kubiak H; Grzegorczyk J; Gendek EG; Kowalski ML; Berner J
Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S89-95. PubMed ID: 11665753
[TBL] [Abstract][Full Text] [Related]
14. [Relation between serum carcinoembryonic antigen (CEA) level and microscopic features of lung cancer].
Ochnio J; Szymańska D; Kwiek S; Rogińska E; Rowińska-Zakrzewska E
Pneumonol Pol; 1984 Jul; 52(7):331-9. PubMed ID: 6093067
[No Abstract] [Full Text] [Related]
15. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
16. [Phagocytic activity in various lung tumors].
Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
[No Abstract] [Full Text] [Related]
17. [The distribution of HLA-system antigens in lung cancer patients].
Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV
Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586
[TBL] [Abstract][Full Text] [Related]
18. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
19. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
20. [CEA distribution in BALF of lung cancer patients].
Xu WB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):371-3. PubMed ID: 2855411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
